STAT

Biotech hedge fund titan Sam Isaly harassed, demeaned women for years, former employees say

NEW YORK — The founder of biotech’s largest and most powerful hedge fund has for years perpetuated a toxic culture of sexual harassment, former employees told STAT, routinely subjecting young female assistants to pornography in the workplace, lewd jokes, and pervasive sexist comments.

Five people who once worked at investing giant OrbiMed Advisors said Sam Isaly, the firm’s 72-year-old managing partner, kept a set of breast implants on his desk, palpating them like stress balls during idle conversation. He wantonly demeaned and verbally abused female employees, they said.

One woman said on several occasions, she glimpsed hardcore pornography playing on the large screens that dominated the trading room floor of the $15 billion fund.

Four women said they repeatedly complained about Isaly’s behavior to senior executives at OrbiMed, getting sympathy, but no action. Though their jobs paid well and came with many perks, the boorish environment eventually drove each to quit, the women said.

“I’m scarred,” Delilah Burke, who was Isaly’s assistant for about 18 months beginning in 2009, said in an interview with STAT. “I still have anxiety from that job — now, years later.”

Isaly denied allegations of sexual harassment and pornography in the workplace in a 90-minute interview with STAT on Monday at OrbiMed’s headquarters.

Moments after this story was published Tuesday evening, OrbiMed issued a statement saying, “The incidents cited are concerning and OrbiMed has retained the services of an outside independent law firm to investigate the matter. OrbiMed takes gender equality seriously and wishes to encourage a supportive work environment and equal opportunity for all employees.”

Earlier Tuesday, shortly before the story was published, OrbiMed partner Carter Neild had emailed STAT: “If this article proceeds I hope that you will be fair and focus on the person responsible, not the entire firm.”

During the Monday interview, surrounded by three colleagues and a crisis-management consultant, Isaly was by turns playful, withdrawn, and agitated, maintaining throughout that he had done nothing wrong. He paused after each question before saying “no” or “not to my

You're reading a preview, sign up to read more.

More from STAT

STAT2 min read
This Troubled Biotech Needed Cash, So It Turned To A Predatory Lender: Its Own CEO
I don’t write about Northwest Biotherapeutics much anymore because it’s not cool to punch down. However, there was a juicy nugget in the cancer biotech’s recently filed 10-Q that had to be shared. It’s another example of a biotech executive getting r
STAT7 min readPolitics
Trump Has Made A Priority Of Trying To Lower Drug Prices. But Many Of His Most Ardent Supporters Don’t Know It
Few of his supporters — even those willing to blast "Big Pharma" or whose ears perked up at the mention of drug importation — had any idea that Trump had…
STAT4 min readScience
Opinion: Gene Editing To Stop Lyme Disease: Caution Is Warranted
I'm inherently cautious about genetically engineering wild species. but in some cases, it may be relatively safe, beneficial to human health, and worth the presumed risks.